Five Factor Score in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss; EGPA): to use or not to use?
about
Clinical Characteristics and Treatment Response of Peripheral Neuropathy in the Presence of Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Experience at a Single Tertiary Center.Response to: 'Five Factor Score in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss; EGPA): to use or not to use?' by Moiseev and Novikov.
P2860
Five Factor Score in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss; EGPA): to use or not to use?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Five Factor Score in patients ...... ; EGPA): to use or not to use?
@en
Five Factor Score in patients with eosinophilic granulomatosis with polyangiitis
@nl
type
label
Five Factor Score in patients ...... ; EGPA): to use or not to use?
@en
Five Factor Score in patients with eosinophilic granulomatosis with polyangiitis
@nl
prefLabel
Five Factor Score in patients ...... ; EGPA): to use or not to use?
@en
Five Factor Score in patients with eosinophilic granulomatosis with polyangiitis
@nl
P2860
P1476
Five Factor Score in patients ...... ; EGPA): to use or not to use?
@en
P2093
Pavel Novikov
P2860
P356
10.1136/ANNRHEUMDIS-2013-204809
P407
P577
2013-11-22T00:00:00Z